Form 4: NeueHealth CFO Jay Matushak Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer of NeueHealth, Jay Matushak, reports the vesting and disposal of restricted stock units.
Summary
- On March 6, 2024, Jay Matushak, the CFO of NeueHealth, reported transactions involving the company's stock.
- Matushak disposed of 6,341 shares of common stock to cover taxes on vesting restricted stock units.
- These restricted stock units vest in three equal annual installments beginning on March 6, 2024.
- Following the reported transactions, Matushak directly owns 9,202 shares of common stock and 12,680 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions, with no inherent positive or negative implications for the company's performance.
Future Outlook
The restricted stock units vest in three equal annual installments beginning on March 6, 2024.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the CFO's personal holdings and does not represent a significant change in the company's overall financial position.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of transaction and first vesting date of restricted stock units. |
| 03/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.